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Abstract
Hematologic measures such as hematocrit and white blood cell (WBC) count are heritable and 
clinically relevant. Erythrocyte and WBC phenotypes were analyzed with Illumina HumanExome 
BeadChip genotypes in 52,531 individuals (37,775 of European ancestry; 11,589 African 
Americans; 3,167 Hispanic Americans) from 16 population-based cohorts. We then performed 
replication analyses of novel discoveries in 18,018 European American women and 5,261 Han 
Chinese. We identified and replicated four novel erythrocyte trait-locus associations (CEP89, 
SHROOM3, FADS2, and APOE) and six novel WBC loci for neutrophil count (S1PR4), monocyte 
count (BTBD8, NLRP12, and IL17RA), eosinophil count (IRF1), and total WBC (MYB). The 
novel association of a rare missense variant in S1PR4 supports the role of sphingosine-1-
phosphate signaling in leukocyte trafficking and circulating neutrophil counts. Loss-of-function 
experiments of S1pr4 in mouse and zebrafish demonstrated phenotypes consistent with the 
association observed in humans and altered kinetics of neutrophil recruitment and resolution in 
response to tissue injury.
Introduction
Erythrocyte and leukocyte blood counts are heritable traits (estimated heritability 0.40–
0.901–3 and 0.14–0.40, respectively4) that reflect core physiologic functions of oxygen-
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carrying capacity and anti-microbial activity. Peripheral blood cell counts are commonly 
measured in the clinical setting to diagnose and monitor therapy of many acute and chronic 
conditions, such as infection or anemia. Abnormalities in these clinical measures often 
reflect primary hematologic disease, blood loss or inflammation. Inter-individual differences 
in erythrocyte traits, total WBC, and neutrophil counts have been associated with risk of 
cardiovascular diseases and all-cause mortality.5–7
Previous genome-wide association studies (GWAS) have defined over 100 loci influencing 
erythrocyte traits8–12 and leukocyte counts.8,13,14 However, few studies have systematically 
evaluated the contribution of coding variation, particularly variants at low frequency in the 
general population.15,16 Recently completed exome sequencing in diverse populations has 
led to international collaboration and creation of a genome-wide catalog of low frequency 
coding variants. We undertook a large-scale study of erythrocyte and leukocyte traits in up to 
52,531 individuals of European, African and Hispanic ancestry to evaluate the impact of 
both low-frequency and common variants assayed by the Illumina HumanExome BeadChip, 
also referred to as the exome chip.
Results
Study Samples
In the discovery stage, we analyzed erythrocyte traits (hemoglobin (Hb), hematocrit (Hct), 
mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration 
(MCHC), mean corpuscular volume (MCV), red cell distribution width (RDW), and red 
blood cell count (RBC)) and leukocyte traits (total WBC count and absolute neutrophil, 
lymphocyte, monocyte, eosinophil, and basophil counts) (Supplementary Table 1) in 52,531 
individuals, including 37,775 with European ancestry (EA), 11,589 African Americans 
(AA), and 3,167 white Hispanics (HA) sampled from 16 population-based cohorts. Sample 
sizes per trait analyzed in each cohort are provided in Supplementary Table 2. The traits 
followed expected distributions, and characteristics of the study participants, including age, 
sex and trait summaries, are presented in Supplementary Table 3. Descriptions of each 
cohort are provided in the Supplementary Note.
Single variant and gene-based meta-analyses
In single variant analyses, we did not observe significant inflation of the meta-analysis p-
values (Supplementary Table 4). A total of 104 unique locus-trait associations exceeded the 
Bonferroni-corrected significance threshold (p<4×10−7; Supplementary Table 5). These 
included 49 independent loci associated with erythrocyte traits and 22 loci associated with 
leukocyte traits (Supplementary Table 6). Many of these were single nucleotide 
polymorphisms (SNPs) well-established to be associated with hematologic traits (see 
Supplementary Note), thus confirming the validity of the exome chip. Novel findings 
reaching study-wide significance (p<4×10−7; n=9 for erythrocytes; n=10 for leukocytes) are 
listed in Table 1 and were carried forward to replication in an independent sample. Of these, 
4 novel trait-locus associations for erythrocyte traits (SHROOM, CEP89, and APOE were 
study-wide significant, p<0.003; FADS2 was only nominally significant, p=0.02) and 6 
novel trait-locus associations for WBC traits (BTBD8, MYB/HBS1L, S1PR4, and IL17RA 
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were study-wide significant, p<0.003; IRF1 and NLRP12 were only nominally significant, 
p<0.05) were replicated in an independent set of European American samples from WHI 
(Supplementary Table 7).
Novel, replicated associations with erythrocyte traits
All 4 novel, replicated erythrocyte associations are common SNPs present on the exome 
chip because of prior associations with non-hematologic phenotypes as listed in the NHGRI 
GWAS catalog. Two common intronic SNPs previously associated with renal function 
(SHROOM3/rs13146355 and CEP89/rs4805834) were associated with both Hb and Hct. 
The minor allele of SHROOM3/rs13146355-A (previously associated with both lower 
estimated glomerular filtration rate (eGFR)17 and higher serum magnesium18) was 
associated with significantly higher Hb and Hct and nominally higher RBC count in our 
discovery and replication cohorts. The minor allele of CEP89/rs4805834-T was associated 
with lower Hb and Hct and higher eGFR.19 The observed directions of effect on Hb and Hct 
for both CEP89/rs4805834 and SHROOM3/rs13146355 are opposite of that expected based 
on the known relationship between lower eGFR and anemia. Conditional analyses 
performed in a subset of our cohorts demonstrated that the effect of either CEP89/rs4805834 
or SHROOM3/rs13146355 on Hb and Hct was independent of eGFR (see Supplementary 
Note for more detail).
An intronic SNP of the fatty acid desaturase gene FADS2 (rs1535) previously associated 
with transferrin levels20 and polyunsaturated fatty acid (PUFA) levels21 was associated with 
RBC count. Finally, we identified an association between increased RDW and the SNP 
encoding the canonical APOE-ɛ2 variant rs7412, which is known to be associated with 
cholesterol22–25 and inversely associated with dementia.26,27 Additional adjustment for 
LDL-cholesterol, HDL-cholesterol, and triglyceride levels did not attenuate the APOE-
ɛ2/RDW association in the ARIC study. A tag for the APOE-ɛ4 allele was present on the 
exome chip, but had no association with either LDL-cholesterol or RDW independent of 
APOE-ɛ2 (Supplementary Note).
In gene-based tests, several loci were significantly associated with erythrocyte traits in the 
discovery sample (Table 2; Supplementary Table 8). The EPO gene-based association was 
driven by a single low-frequency missense variant (p.Asp70Asn/rs62483572), confirming 
the recent association of this variant with lower Hb.16 Similarly, a single novel variant drove 
the ITFG3 association (p.Asp534Asn/rs144091859). The HFE and G6PD associations were 
driven by population-specific common variants identified in prior GWAS that were included 
in the gene-based test because they are common in one population but absent in another and 
therefore averaged out to below the minor allele frequency (MAF) <0.05 threshold for 
inclusion in the trans-ethnic analysis. Significant associations in ANK1, NLRC3, and 
HBS1L were supported by multiple rare variants (Supplementary Table 9a; Supplementary 
Note).
Novel, replicated leukocyte associations
We discovered and replicated 6 novel WBC trait-locus associations. In the single-variant 
analysis, we identified a single missense variant in the type 4 sphingosine-1-phosphate 
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receptor (S1PR4), p.Arg365Leu/rs3746072, that was associated with lower total WBC 
(p=1.5×10−7) and lower neutrophil counts (p=3.4×10−7) (Supplementary Figure 1). The 
association was consistent across cohorts (Figure 1) and validated in both replication 
samples (WHI EA women p=0.001; PUUMA Han Chinese p=0.003; p-
metadiscovery+replication=5×10−12) (Supplementary Table 7). The variant is rare 
(MAFmeta=0.006) and not in linkage disequilibrium with variants in the region 
(Supplementary Figure 1). In both discovery and replication analyses, p.Arg365Leu was the 
only variant contributing to the significant gene-based association. Neutrophil counts were 
approximately 10% lower in the p.Arg365Leu minor allele carriers (Figure 2). The S1PR4 
p.Arg365Leu amino acid substitution is located in the intracellular cytoplasmic tail of 
S1PR4, is at a conserved site (GERP: 3.94), and is predicted to be “possibly damaging” by 
PolyPhen-2.28
Two missense variants were associated with lower monocyte count: a low-frequency 
p.Val60Ile variant in BTBD8 (rs34856868; MAFEA=0.03) and a common p.Gly39Val 
variant in NLRP12 (rs34436714; MAFEA=0.217). Three common, intergenic variants 
included on the exome chip as GWAS index SNPs originally associated with non-leukocyte 
phenotypes were newly associated with WBC traits in our analysis. The common intergenic 
regulatory variant of HBS1L-MYB (previously associated with erythrocyte and platelet 
traits) was associated with total WBC count. Common non-coding SNPs in the regions of 
IL33 and IRF1 previously associated with asthma29 and other allergic/autoimmune 
disorders30–33 were associated with eosinophil count.
Gene-based analyses identified an association between low frequency variation in the 
IL17RA locus and monocyte count (p=6.4×10−7). We confirmed the recently reported multi-
variant association between CXCR2 and lower neutrophil count; 6 of the 9 rare CXCR2 
missense variants in our analysis had a p-value less than 0.05, with the strongest associations 
from p.Arg153His (rs55799208; p=2.4×10−5) and p.Arg248Gln (rs61733609; p=6.1×10−5). 
Several additional single-variant and gene-based associations with WBC traits were 
observed within the AA or HA discovery samples, but not in the larger EA discovery 
sample. Three of these associations were driven by low frequency (MAF 0.01–0.05) variants 
in AAs (IQCJ and SEC24D) or HAs (SEC14L1) (Table 1b and Supplementary Tables 8 and 
9b). Further assessment in independent AA or HA samples will be needed to validate these 
ethnicity-specific associations.
Characterization of variants in previously known GWAS loci
To evaluate whether variants identified in our analysis overlap previously known GWAS 
results or whether we identified independent associations, we conducted conditional 
analyses in ARIC, adjusting for previously known variants associated with erythrocyte and 
leukocyte traits in several regions overlapping the findings in this study (Supplementary 
Table 10). Specifically, we interrogated any variant that was rare (MAF<5%) and meeting 
study-wide significance (Supplementary Note).
We identified a novel association between a low-frequency variant in ANK1 (p.Ala1462Val/
rs34664882; MAFEA=0.029; MAFAA=0.015; MAFHA=0.013) and MCHC that is 
independent of the original GWAS result (rs4737009; 1000G CEU MAF=0.27; ARIC 
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MAFEA=0.24). We also identified several low-frequency missense variants in the HBA1-
HBA2 region on chromosome 16. The most prominent was an AA-specific variant in ITFG3 
(p.Asp534Asn) that was associated with several erythrocyte parameters (MCH, MCHC, 
MCV, RBC count) and is independent of the common GWAS association (see 
Supplementary Note). Significant associations with the same traits were also seen for rare 
variants in MRPL28, NARFL, RGS11, TMEM8A, and TPSD1 (see Supplementary Note).
Expression quantitative trait loci (eQTL) analysis
We used eQTL analysis34 to determine if newly identified non-coding variants are associated 
with expression of nearby genes across a range of tissue types (Supplementary Table 11). 
The most notable eQTL findings were in the FADS2 locus, which was associated with RBC 
count in our discovery analysis and met a nominal significance level in the replication 
analysis (p=0.02). In this region, FADS1, FADS2, and FADS3 all showed evidence of strong 
cis eQTL association to either the index SNP (rs1535) in multiple tissues, including FADS1 
(minimum p= 8.0×10−31 in CD19+ B cells) and FADS2 (minimum p= 3.0×10−57 in blood 
lymphocytes). The S1PR4 p.Arg365Leu variant does not demonstrate an association with 
expression levels of S1PR4 or any nearby transcript (Supplementary Table 12).
Among the novel and independently replicated loci, rs4895441 at the HBS1L-MYB locus 
showed the expected eQTL association with HBS1L expression in multiple tissues 
(minimum p=3.1×10−34 in aortic endothelial cells). In the SHROOM3 locus, rs131463 
exhibited a weak eQTL association (p=7.3×10−6) with SHROOM3 transcript expression in 
subcutaneous adipose tissue. In the CEP89 locus, rs4805834 was associated with expression 
of SLC7A9 in multiple tissue (p=1.9×10−24 in whole blood). The IRF1 SNP, rs12521868, 
was associated with expression of IRF1 in multiple tissues (p=1.4×10−125 in whole blood).
Pleiotropy in the associated loci
In addition to pleiotropy between our novel findings and the known associations with kidney 
function (CEP89 and SHROOM3) and with dementia and dyslipidemia (APOE), we also 
identified variants with pleiotropy across multiple blood cell lineages, most notably for the 
HBSL1-MYB and SH2B3 loci as well as other subthreshold associations (see 
Supplementary Note; Supplementary Table 13).
Confirmation of S1PR4 as a causal gene in model systems
The primary hypothesis of our exome chip study was that focused evaluation of coding 
variation would yield novel genetic associations of rare variants with hematologic traits, and 
that these variants would be more likely to be functionally relevant owing to the selection of 
variants for the exome chip. Our study yielded many novel associations, in part due to 
coverage of noncoding variation included in the exome chip as follow-up of previous 
GWAS, as is the case for the three novel RBC loci we report here. The association of a rare 
missense variant in S1PR4 associated with total WBC and neutrophil count was consistent 
with our a priori hypothesis, and we therefore undertook further follow-up studies of this 
gene’s functional impact on neutrophil traits in model systems.
Pankratz et al. Page 5
Nat Genet. Author manuscript; available in PMC 2017 January 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Using previously generated S1pr4 null mice,35 we evaluated peripheral circulating blood 
neutrophil and monocyte counts, bone marrow neutrophil counts, and spleen neutrophil 
counts in S1pr4−/− mice and S1pr4+/+ littermates. We analyzed 12 mice in each genotype 
group (total n=24 mice), with equal numbers of males and females in each group, and found 
the mean percentage of total cells analyzed by fluorescence-activated cell sorting (FACS) 
that were Gr1+ CD11b+, marking neutrophils, was 31% lower in S1pr4−/− mice compared to 
wild-type mice. We repeated the experiment again in an additional 24 mice, again with 12 
mice in each genotype group and equal numbers of males and females in each group and 
saw a similar decrease. Across the 48 mice, both the percentage of white blood cells that 
were neutrophils (28.0% decrease; p=0.11) and the absolute neutrophil count (54.3% 
decrease; p=0.03) were lower in S1pr4−/− mice compared to wild-type mice (Figure 3; 
Supplementary Figure 2; Supplementary Table 14). To evaluate the effects on circulating 
monocyte counts, FACS analysis was conducted in the same samples, and the mean 
percentage of total leukocytes analyzed by FACS that were Gr1- CD11b+ was equivalent in 
the two mouse groups (6.36% in S1pr4+/+ mice and 6.20% in S1pr4−/− mice, p=0.80, 
Supplementary Figures 3–4). Since abnormalities of leukocyte bone marrow egress have 
been described in the setting of S1pr1 deficiency,36 we evaluated the proportion of 
neutrophils in the bone marrow and spleen, to evaluate whether cells may be abnormally 
retained in these tissues, and the expression of specific adhesion molecules involved in 
leukocyte trafficking. No significant differences in neutrophil proportions or absolute counts 
were observed in the bone marrow or spleen (Supplementary Table 14, Supplementary 
Figures 3–6). Cd49b and Cxcr4 expression on bone marrow neutrophils were not 
differentially expressed (p>0.05), whereas Cd62l, or L-selectin, expression measured on 
circulating neutrophils was reduced approximately 2-fold in the S1pr4−/− mice (p=0.003) 
across both groups of mice studied. Since lower L-selectin expression may reflect shedding 
upon activation and cell extravasation in tissues, we evaluated tissue neutrophil numbers in 
the liver and lung of S1pr4−/− and wild-type mice. Neutrophil numbers were lower in both 
tissues in S1pr4−/− mice, with a 29.2% reduction in liver (p=0.12) and 40.2% reduction in 
lung (p=0.02) Supplementary Figure 7).
To further assess the impact of disrupted s1pr4 expression in vivo, we conducted parallel 
experiments in zebrafish in which gene expression may be manipulated readily using 
morpholino (MO) antisense technology to specifically knock down the expression of target 
genes.37 In the comparison of embryos injected with ATG-MO’s designed against two 
independent sequences (Supplementary Note) within the single exon of s1pr4 (n=14 and 19) 
to non-specific MO (n=22), we confirmed a 36.6% and 34.3% decrease in neutrophil count 
in the two batches of whole embryos at two days post fertilization (dpf) (p=3.8×10−6 and 
p=4.4×10−7, respectively) (Figure 4; Supplementary Table 15).
Finally, to assess neutrophil behavior in response to injury, a cutaneous wound was made on 
the ventral side of the tail fin of the embryos at 2 dpf after treatment with the s1pr4 MO 
versus uninjected controls, and the numbers of neutrophils around the wound area at 
intervals up to five hours post injury were counted to quantify neutrophil recruitment and 
resolution in response to the injury. The overall number of neutrophils recruited to the 
wound was higher and took place faster in embryos treated with s1pr4 MO; however, after 
initial recruitment a trend for higher reverse migration rate and fewer cells retained at the 
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site of injury in the s1pr4 morphants (Supplementary Table 16) suggests that the time course 
of neutrophil response to injury and/or resolution of inflammation may be altered in the 
setting of decreased s1pr4 expression (Figure 5).
Discussion
Using a custom genotyping array with focused coverage of missense and loss-of-function 
variants in exonic regions, we conducted an analysis of erythrocyte and leukocyte traits in as 
many as 52,531 individuals of European, African and Hispanic ancestry. We identified and 
replicated 9 novel genetic loci associated with inter-individual differences in blood cell traits 
and have extended the role of several common variants previously associated with non-
hematologic traits to erythrocyte or WBC phenotypes. Of these new findings, we identified a 
novel association between a rare missense variant in S1PR4 and WBC and neutrophil 
counts, and confirmed a role for this gene in two model organisms. Our findings highlight 
the importance of genes involved in erythrocyte membrane composition and leukocyte 
trafficking in the regulation of peripheral erythrocyte and WBC phenotypes.
The rare missense variant in S1PR4 (p.Arg365Leu/rs3746072; MAFmeta0.006) was robustly 
associated with total WBC count and neutrophil count. S1PR4 belongs to a family of G-
coupled protein receptors for spingosine-1-phosphate (S1P), a lysophospholipid which 
functions as an extracellular signaling molecule with diverse biologic functions, including 
leukocyte trafficking.38 Another S1P receptor subtype, S1PR1, plays an important role in 
regulating immune cell function and lymphocyte trafficking by regulating egress of 
lymphocytes from bone marrow and lymphoid tissues;39–41 however, much less is known 
about the function of S1PR4. S1PR4 is expressed on hematopoietic and lymphoid cells and 
has been implicated in terminal megakaryocyte differentiation to platelets,42 and the 
regulation of dendritic cell function and T(H)17-cell43 and plasmacytoid dendritic cell44 
differentiation. S1PR4 is highly expressed in neutrophils and lymphocytes. In the setting of 
combined s1p lyase and S1pr4 deletion in mice, neutrophilia and inflammation are 
decreased compared to S1P lyase deficiency alone. This suggests that S1PR4 may mediate 
the higher neutrophil count that accompanies highly elevated S1P levels in mice with S1P 
lyase deficiency.35,45
Here, we confirm in two in vivo vertebrate model systems (mouse and zebrafish) that loss of 
S1pr4 function leads to lower basal numbers (and proportion) of circulating neutrophils, 
consistent with the association observed in human p.Arg365Leu carriers. The mild reduction 
in neutrophil count suggests a hypothesis of abnormal neutrophil trafficking, rather than a 
critical role in neutrophil development. Bone marrow egress of leukocytes is known to be 
impaired in the setting of S1pr1 deficiency.39–41 We therefore examined the expression of 
previously defined key adhesion molecules for leukocyte migration in response to S1P 
signaling in the bone marrow neutrophils of S1pr4 null mice, including CD49b, which is 
abnormally expressed in S1pr1 and S1P lyase deficient states,36 and CXCR4, which 
interacts with the cytokine peptide SDF-1 required for cellular bone marrow egress.46,47 We 
did not find any alterations of these adhesion molecules, and we did not observe 
accumulation of neutrophils in the bone marrow or spleen, which corroborates a lack of 
effect on egress of neutrophils. Because neutrophil recruitment to injured or infected tissue 
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is a key process, we evaluated neutrophil CD62L surface expression, which mediates 
interactions between the neutrophil and endothelium and is required for leukocyte trafficking 
across the endothelial border.48 CD62L neutrophil expression was reduced approximately 
two-fold in the S1pr4 null mouse. Since CD62L is shed from the surface of neutrophils upon 
activation and mediates leukocyte extravasation into tissues, we examined whether tissue 
neutrophil counts were elevated in the S1pr4 null mouse, accounting for lower circulating 
neutrophil counts. However, tissue neutrophil numbers were not increased in the S1pr4 null 
mouse compared to the wild-type; rather they were similarly decreased as in the blood.
In the zebrafish s1pr4 morphants, neutrophil accumulation and resolution at the site of a 
cutaneous wound occurred earlier than in controls, suggesting impaired cellular 
inflammation in response to tissue injury. Further experiments to delineate neutrophil-
endothelial cell interactions will be needed to delineate further the precise mechanisms by 
which S1PR4 impacts circulating neutrophil counts. Together, our observations support the 
role of S1PR4 in the regulation of neutrophil counts and potentially clinically relevant 
impairment in response to injury or infection.
Blood monocyte counts are altered in the setting of chronic inflammatory disease and 
various infections, both viral and non-viral. NLRP12 is a member of a sub-group of a non-
inflammasome forming NLR family that attenuates inflammation by suppressing NF-κB 
signaling in activated monocytes.49 NLRP12 loss-of-function mutations have been identified 
in families with hereditary periodic fever syndromes50. The missense variant reported here, 
p.Gly39Val, was not reported in these families and is not present in the ClinVar database.51 
In humans and mice, NLRP12 is highly expressed in bone marrow, and macrophages from 
Nlrp12-deficient mice exhibit decreased chemotaxis in response to chemokines in vitro 
suggesting that NLRP12 is important for leukocyte cell trafficking.52 IL17RA is a 
proinflammatory cytokine with a role in hematopoietic cell maturation, and vascular 
IL-17RA supports monocyte adherence.53,54 Mutations in IL17RA are associated with 
familial candidiasis.55
Eosinophil counts are altered in parasitic infection, allergic and autoimmune diseases such 
as asthma and inflammatory bowel disease. The IL33 variant rs1342326 has previously been 
associated with asthma,29 and IL33 activates eosinophils.56 The IRF1 variant (rs12521868), 
which we show to be associated with IRF1 expression, has been previously associated with 
Crohn’s disease.57 IRF1 is also near IL5, a known regulator of eosinophil production 
previously associated with eosinophil count.58
We observed novel erythrocyte trait associations for common non-coding SNPs representing 
two genomic regions previously associated with kidney function, near SHROOM3 and near 
CEP89.19,59 For both loci, the allele associated with lower Hb and Hct was associated with 
higher eGFR,17 suggesting that these erythrocyte trait associations are not mediated through 
an effect of renal dysfunction and related decreased erythropoietin production. The 
SHROOM3 locus has additionally been associated with serum magnesium levels.18 The 
effects of these two loci on erythrocyte, renal, and electrolyte traits may occur instead 
through cytoskeleton-dependent solute/ion channels shared between kidney epithelia and 
erythrocyte membranes, as has been demonstrated in other examples such as PIEZO1, 
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another GWAS locus for erythrocyte traits. PIEZO1 is a RBC membrane mechano-sensitive 
cation channel that appears to require actin cytoskeleton reorganization60,61 and senses 
mechanical forces associated with fluid flow and/or circumferential stretch in epithelial cells 
at the basolateral side of renal proximal convoluted tubules.62–64 Dominant missense 
mutations of PIEZO1 have been reported in patients with hereditary xerocytosis,65 a 
congenital hemolytic anemia characterized by dehydrated, shrunken erythrocytes and the 
presence of stomatocytes due to increased potassium permeability. By analogy, SHROOM3 
is an actin-binding protein involved in epithelial shape regulation, modulating ion channel 
activity through myosin II-dependent cytoskeletal re-organization in the kidney.66 Its role in 
erythrocyte function has yet to be tested experimentally. CEP89 is a ubiquitously expressed 
and highly conserved gene for which biologic function is not well known. CEP89 is flanked 
by SLC7A9, a kidney solute transporter. Mutations in SLC7A9 result in congenital 
cystinuria.67 Our eQTL analyses showed a significant association of the index SNP 
associated with Hb and Hct and SLC7A9 transcript levels in multiple tissue types and most 
strongly in whole blood, supporting a possible hematologic function.
FADS1 and FADS2 encode the two rate-limiting desaturases in the conversion of dietary 
essential medium-chain PUFAs (e.g., α-linoleic acid [ALA]), to long-chain PUFAs 
(arachadonic acid, eicosapentaenoic acid [EPA], docosahexaenoic acid [DHA]). The minor 
allele of the FADS2 intronic variant rs1535-G is associated with higher levels of ALA and 
lower levels of EPA and DHA. This suggests less efficient conversion due to decreased 
FADS activity,21 as well as cholesterol levels and pro-inflammatory eicosanoids.68 Here we 
report that the same FADS2 allele is associated with higher RBC count, Hb and Hct. rs1535 
is in strong LD with other common SNPs in the FADS1-FADS2 region on chromosome 
11q12.2, including several eQTL SNPs for FADS1. Our eQTL analysis of this region 
showed strong associations of these SNPs with FADS1, FADS2 and FADS3 expression 
levels. Long-chain PUFAs are incorporated into erythrocyte membrane glycerolipids, 
affecting erythrocyte membrane fluidity, permeability, and sensitivity to oxidative damage 
and subsequent hemolysis.69 Nonetheless, the association of rs1535 with higher RBC count 
suggests additional mechanisms. In this regard, rs1535 is also located ~100 kb from FTH1, 
which encodes the heavy subunit of ferritin, the major intracellular iron storage protein 
which is expressed in both mature erythrocytes and early erythroid precursors.
Pleiotropy (i.e., more than one trait associated with the same locus) was observed for 
erythrocyte associations at the CEP89, FADS1 and HFE loci, and we extended the 
association of the well-characterized common HBSL1-MYB regulatory variant, previously 
associated with erythrocyte and platelet traits, to WBC count. MYB encodes c-Myb, a 
transcription factor and proto-oncogene expressed in immature hematopoietic cells and 
leukemic cells that plays an essential role in the regulation of normal hematopoiesis and 
leukemogenesis.70 In addition, we confirmed the previously reported association of the 
chromosome 12q24 SH2B3 region with erythrocyte and WBC traits; this locus has been 
associated with multiple cardiovascular and inflammatory traits and diseases.9,71–73
Our results add to recent observations that rare coding variants contribute to phenotypic 
differences in complex blood cell traits among community-dwelling individuals unselected 
for hematologic disorders. Experimental testing of S1PR4 loss of function in vivo, 
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performed to follow up a S1PR4 rare missense variant association in our study, showed 
novel biologic effects on neutrophil count and function. Common variants originally 
associated with a single blood cell trait through GWAS, such as SH2B3, have subsequently 
been associated with traits related to all 3 blood cell lineages,10,74 as well as non-
hematologic traits,73,75,76 and these pleiotropic effects will be useful to discern patterns 
suggesting specific biologic hypotheses for further mechanistic hypothesis testing.
Methods (online)
Study Samples
Our discovery sample consisted of exome chip data from 52,531 individuals, including 
37,775 European Americans (EA), 11,589 African Americans (AA), and 3,167 Hispanic 
Americans (HA) sampled from 16 population-based cohorts participating in the CHARGE 
Consortium77: Age, Gene/Environment Susceptibility study (AGES), Atherosclerosis Risk 
in Communities (ARIC) Study, Cardiovascular Health Study (CHS), Family Heart Study 
(FamHS), Framingham Heart Study (FHS), Health ABC (HABC), Health2006/2008, the 
Mount Sinai Institute for Personalized Medicine BioMe Biobank Project (BioMe), Jackson 
Heart Study (JHS), the Lothian Birth Cohorts 1921/1936 (LBC), Multi-Ethnic Study of 
Atherosclerosis (MESA), the Rotterdam Study (RS), the Women’s Health Initiative (WHI; 
AAs only), and the Cardiovascular Risk in Young Finns Study (YFS). The replication 
sample consisted of 17,500 samples from the Women’s Health Initiative (WHI; EAs only) 
and 5,261 Han Chinese individuals from the Peking University – University of Michigan 
Study of Atherosclerosis (PUUMA). Descriptions of each of the cohorts and the techniques 
used to measure the hematologic traits are provided in previous publications (Supplementary 
Note) and summarized in Supplementary Table 1. All participants provided written informed 
consent as approved by local human-subjects committees.
Erythrocyte and Leukocyte Phenotypes
The hematology traits we studied included hemoglobin concentration (Hb), hematocrit 
(Hct), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean 
corpuscular hemoglobin concentration (MCHC), red blood cell (RBC) count, red cell 
distribution width (RDW), total white blood cell (WBC) count, and counts of the WBC 
subtypes neutrophils, monocytes, lymphocytes, basophils, and eosinophils, using the 
transformations defined in Supplementary Table 1. Traits were harmonized across cohorts 
for the same units of measurement, and within each cohort, traits were transformed 
according to standard convention (Supplementary Table 1). We Winsorized values greater 
than three standard deviations of the population mean for each trait in each cohort in order to 
reduce false positives caused by extreme outliers while still maintaining power to identify a 
potential signal with strong effect.
Genotyping and quality control
Genotypes were assayed using the Illumina HumanExome Beadchip (Illumina, Inc., San 
Diego, CA) in accordance with the manufacturer’s instructions. Genotype calls were 
assigned using GenomeStudio v2010.3. Samples were excluded if any of the following 
applied to them: a call-rate less than 95%, ethnic outlier in a principal components analysis, 
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evidence of contamination, sex mismatch, or unexpected cryptic relatedness. SNPs were 
excluded with call-rates less than 95% or if they deviated from Hardy-Weinberg at 
p<5×10−6. For the SNPs identified by the association analyses, the cluster plots were 
visually inspected.
Association analysis of single variants and implementation of gene-based tests
Variants were annotated using dbNSFP v2.0.78,79 Phenotypes were first transformed (either 
natural log transform, square root, or none at all, as delineated in Supplementary Table 1 and 
then Winsorized at 3 standard deviations (mean and standard deviation was computed 
separately for each cohort and the threshold was computed as mean±3 standard deviations; 
any individual with a value exceeding this threshold was replaced with this threshold). Age, 
sex, study (if needed), and principal components were included as covariates in the analyses. 
The R skatMeta (v1.4.2) package was used for all cohort-level analyses. Each study used 
either the skatCohort or the skatFamCohort function to create an R object that was then 
uploaded to a central server.
After performing quality control of the genotypes as described previously,80 we analyzed 
247,870 SNPs meeting quality control, using single variant association tests and gene-based 
tests of aggregate variants. For single variant association tests, a minor allele count filter of 
at least 40 was used for each trait. As a secondary analysis, we lowered this filter to a minor 
allele count of 10 or greater, to evaluate for any lower frequency alleles with strong effects 
(Supplementary Note; Supplementary Figure 8). For gene-based testing, only coding 
variants putatively affecting protein structure (missense, stop-gain, stop-loss, and splice 
variants) that also had a frequency < 5% in a given population (~200,000 SNPs) were 
included.
In parallel with the single-variant association tests, we conducted aggregate variant testing 
using two methods: the T5 test81 (MAF < 0.05) and the SKAT test82 (MAF < 0.05, Wu 
weights). The T5 test identifies those genes where multiple samples have private or rare 
mutations leading to a strong effect in a single direction. The SKAT test allows for different 
variants to have effects in different directions. In both tests, only those variants with a 
possible effect on amino acid sequence (missense, stop-gain, stop-loss, and splice variants) 
were included in the analysis.
Meta-analysis of single variant and gene-based tests
Single variant and gene-based association statistics were combined in a fixed-effects, 
inverse-variance weighted meta-analysis and performed in parallel at two different sites 
using the same skatMeta package. Analyses were stratified first by ancestry and then 
combined in a trans-ethnic analysis using the same methodology. Results for single variant 
analyses were reported only when 40 or more minor allele counts were observed, and a 
Bonferroni correction for the number of tests was employed to determine significance. For 
gene-based tests, two different methods were employed. The first was the Combined 
Multivariate and Collapsing (CMC) approach,81 where the number of qualifying variants in 
each gene were added together for each individual separately and then used as the predictor 
in a linear regression model. To be included, a variant had to have an average allele 
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frequency less than 5% across all cohorts and also change the amino acid sequence of an 
mRNA, either as a missense, stop-gain, stop-loss, frameshift or splice site variant. The 
second method was the SKAT method82 and used the same set of variants as the CMC/T5 
approach. Only those genes with a minor allele count greater than 40 were analyzed, and a 
Bonferroni correction for the number of genes tested was employed to determine 
significance. The number of individuals with each of the hematologic traits under study 
differed, and consequently the number of markers reaching our minor allele count threshold 
of 40 varied by trait. We therefore applied trait-specific p-value thresholds, according to the 
number of variants available for the individuals with each trait (Supplementary Table 5).
Independent replication analysis
We conducted follow-up replication analysis in 18,018 independent EA samples from the 
Women’s Health Initiative (WHI) and 5,261 Han Chinese individuals from the Shijingshan 
district of Beijing that participated in the Peking University – University of Michigan Study 
of Atherosclerosis (PUUMA) (Supplementary Note). Both studies were genotyped using an 
Illumina HumanExome BeadChip genotyping array and had erythrocyte and WBC traits 
available.16 All novel, significant (p<trait-specific Bonferroni threshold) variant associations 
from the discovery results were tested in the replication analysis. Gene-based test results that 
were significant in the discovery analyses were tested in the replication samples, with the 
exception of HFE and PIGM/DARC since these loci have previously well-defined, known 
signals and were also seen in the single variant analyses. In the case where an association 
was identified in the discovery analysis with an erythrocyte trait other than Hb or Hct, we 
analyzed the association with Hb and Hct in the replication analysis. Similarly, in the case 
where a leukocyte subtype association was found in the discovery analyses, we analyzed 
those variants’ association with total WBC in the replication analysis. We applied a 
Bonferroni correction to the number of replication tests we conducted for the single variant 
analyses (p-value = 0.05 / 19 = 0.003) and for the gene-based tests (p-value = 0.05 / 10 = 
0.005).
Expression quantitative trait loci (eQTL) analysis—We identified proxy SNPs in 
high linkage disequilibrium (LD; r2>0.8) with associated index SNPs in 3 HapMap builds 
and 1000 Genomes with SNAP83. SNP rsIDs were searched for primary SNPs and LD 
proxies against a collected database of expression SNP (eSNP) results (Supplementary 
Note). The collected eSNP results met criteria for statistical thresholds for association with 
gene transcript levels as described in the original papers.
Mouse experiments—S1pr4+/− mice on a C57Bl/6 background (stock number 005799) 
were obtained from The Jackson Laboratory, Bar Harbor, ME.35 Mice were housed in a 
clean conventional facility that excluded specific mouse pathogens. All animal procedures 
were approved by the National Institute of Diabetes and Digestive and Kidney Diseases and 
were performed in accordance with the National Institutes of Health guidelines. Because 
neutrophil counts are known to exhibit a high degree of variability within the same mouse 
and between mice, and by sex,84,85 we studied a total of 48 mice. The first 24 mice (6 
S1pr4−/− females, 6 S1pr4−/− males, 6 S1pr4+/+ females, and 6 S1pr4+/+ males) were all 
littermates (“Experiment 1” in Supplementary Table 14). In a second set of confirmatory 
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experiments, 12 S1pr4−/− mice were compared to 12 C57BL6 controls (Jackson Labs), again 
with equal proportions of males and females in each genotype group (“Experiment 2” in 
Supplementary Table 14). Mice were genotyped by multiplex PCR from tail snips using the 
set of primers and conditions as previously described.35 Mice were analyzed between 2 and 
4 months after birth.
Total bone marrow cells were isolated from mice by flushing the femur and tibia from both 
legs two times with 1 ml of PBS. To obtain total leukocytes, spleen was dissected and 
mechanically disaggregated. Single-cell suspensions were obtained using a 40-μm cell 
strainer. Blood samples were obtained by cardiac puncture. Erythrocytes were removed by 
ammonium chloride lysis. Absolute blood cell counts were determined by flow cytometry 
using CALTAG counting beads (Life Technology, Grand Island, NY), and % neutrophils of 
the total leukocyte pool were calculated and analyzed to account for any possible pipetting 
error. Neutrophils were analyzed by flow cytometry as previously described.35 All 
antibodies were purchased from BD Bioscience, San Jose, CA and were used in 1/50 
dilutions. Briefly, cells were diluted in 1% BSA-PBS and incubated with anti-FcgR antibody 
(catalog # 553141 clone 2.4G2) followed by the antibodies anti-mouse Gr-1 
(allophycocyanin [APC]-conjugated) (catalog # 553129 clone RB6-8C5) and anti-mouse 
CD11b (phycoerythrin [PE]-conjugated) (catalog # 553311 clone m1/70). Cells were also 
incubated with anti-mouse CD62L (catalog # 553150 clone MEL-14), CD49d (catalog # 
553156 clone R1-2) and CXCR4 (catalog # 551967 clone 2B11/CXCR4) (all three 
antibodies were fluorescein-conjugated). After cells were labeled for 30 minutes on ice, and 
fixed in 1% paraformaldehyde in PBS, then subjected to flow cytometry on a FACScalibur 
(BD Bioscience). Data were analyzed using the FlowJo software (Tree Star, Ashland, OR). 
Neutrophils were identified as Gr-1+ CD11b+ cells, and monocytes were identified as Gr-1- 
CD11b+ cells.
Zebrafish experiments—Zebrafish ortholog s1pr4 was identified by sequence homology 
searches and gene synteny analysis, and MO design also incorporated information about 
gene structure and translational initiation sites (Gene-Tool Inc., Philomath, OR). Two 
separate MO’s were designed against s1pr4, which is a single exon gene, in the ATG region 
to inhibit its mRNA translation (see Supplementary Table 15) MOs were injected at multiple 
doses into one-cell stage embryos of the mpx1-gfp zebrafish line to find the optimal dose, 2 
ng/embryo, and the number of gfp-expressing cells was imaged under a spinning-disk 
confocal microscope and counted at 2 days post fertilization. Experiments were conducted in 
>10 each of control and morphant embryos. The day 2 cutaneous injury was created 2 days 
after MO injection by nicking the tail fin, and the number of gfp+ cells at the site of the 
cutaneous wound was counted at 30 minutes, and 1, 2, 3, 4, 5, 6, and 8 hours post injury. 
Paired, one-tailed t-tests were computed for the comparison groups, and linear regression 
analysis of neutrophil numbers at the cutaneous wound in the time series was performed. 
Experiments were done in replicates of at least 10 embryos by a technician and analysis was 
checked by a postdoctoral fellow blinded to MO injection status.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
▪ Exome chip analysis identified loci associated with RBC and WBC traits 
that were replicated in an independent sample
▪ Systematic assessment of coding variation identified candidate causal genes
▪ A low frequency S1PR4 missense variant was robustly associated with 
neutrophil counts
▪ Loss-of-function experiments in vivo in murine and zebrafish models 
confirmed S1PR4 function in maintaining circulating neutrophil counts, 
consistent with the effect observed in humans
▪ S1PR4 appears to play a role in recruitment and resolution of neutrophils in 
response to tissue injury
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Figure 1. 
Forest plot of S1PR4 p.Arg365Leu for neutrophil count and total WBCs. Betas and 95% 
confidence intervals for each contributing study and for each meta-analysis
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Figure 2. 
Distributions of neutrophil counts for carriers and non–carriers of S1PR4 p.Arg365Leu in 
ARIC.
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Figure 3. Blood neutrophils in S1pr4−/− mice
(A–C) Neutrophil numbers. Blood cells from 2–4 month–old S1pr4+/+ (n=24) and S1pr4−/− 
(n=24) mice were stained with anti–Gr–1 and anti–CD11b antibodies and analyzed by flow 
cytometry. Neutrophils were identified as Gr–1high CD11b+. Results are shown as density 
plots (A), as absolute numbers per μl of blood (B) and as the percentage of cells analyzed 
(C). (D–G) Adhesion molecule expression on blood neutrophils. Blood neutrophils from 
S1pr4+/+ and S1pr4−/− mice were analyzed by flow cytometry for the expression of CD49d 
(D), CD62L (E, F) and CXCR4 (G). Expression of CD49 is shown as percentage of Gr1+ 
CD11b+ CD49high (immature neutrophils) and Gr1+ CD11b+ CD49low (mature neutrophils) 
(D). Expression of CD62L (F) and CXCR4 (G) on Gr1+ CD11b+ cells are shown as mean 
fluorescence intensity (MFI). Representative histogram analysis showing the CD62L 
expression for S1pr4+/+ neutrophils (blue line), S1pr4−/− neutrophils (red line) and the 
corresponding isotype control staining (green line) (E). The bars represent mean values, and 
the closed circles are individual mice. S1pr4+/+ (open bars) and S1pr4−/− (red bars). 
Student’s t test *p < 0.05; **p < 0.01; ns, not significant.
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Figure 4. Reduction in neutrophil counts in zebrafish embryos with decreased s1pr4 expression 
by morpholino knock–down with two independent morpholino oligonucleotides
Representative images of zebrafish mpx–gfp fish are shown, demonstrating decreases in 
neutrophil number in s1pr4 morphants at 2 dpf. (A-C) The top set of panels are composite 
images of differential interference contrast (DIC), the middle panels are images using 
fluorescence (green channel), and the bottom panels are black and white images of the 
fluorescent signal of the same embryo injected at 2 dpf with either (A) non–specific MO, (B) 
2 ng/embryo morphlino 1, or (C) 2 ng/embryo morphlino 2; D) distribution of average 
numbers of neutrophils across s1pr4 MO 1 (n=14), s1pr4 MO 2 (n=19) and non-specific MO 
(n=22). ****Student t–test p–value < 0.0001. Scale bar represents 300 μm and is the same 
for all panels.
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Figure 5. Neutrophil migration in response to injury is altered in embryos with low S1pr4 gene 
expression
Neutrophil recruitment and resolution in zebrafish at site of cutaneous wound in the tail fin. 
A series of images from time–lapse movies of control (A) and s1pr4 morphant (B) embryos 
post injury. The red squares mark the injury area where numbers of neutrophil were counted. 
Green = mpx:GFP marked. Quantification plots are shown for the number of neutrophils in 
the marked injury area over time post injury (C). Scale bar represents 200 μm and is the 
same for all panels.
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